Agitation is one of the most challenging symptoms of Alzheimer disease—for both clinicians and caregivers. This FAQ answers the most common questions about recognizing, managing, and treating agitation,...
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...
A recent study examined the effectiveness of a test that uses measurement of compounds found in saliva to predict the risk of developing Alzheimer's disease.
A recent study examined the effectiveness of a test that uses measurement of compounds found in saliva to predict the risk of developing Alzheimer's disease.
A team led by UCLA researchers have validated a technique they say is the first “gold standard” for measuring atrophy in the brain’s hippocampus, an early indicator of Alzheimer’s disease.
A team led by UCLA researchers have validated a technique they say is the first “gold standard” for measuring atrophy in the brain’s hippocampus, an early indicator of Alzheimer’s disease.
Researchers at the Mayo Clinic have identified a very simple new scoring system that may be helpful in predicting which elderly patients are at risk of developing mild cognitive impairment.
